Tricol Biomedical, Inc.


Tricol Biomedical, Inc. (formerly HemCon Medical Technologies, Inc.) is a global leader in hemostasis and infection control products with a full range of devices under the HemCon brand indicated for professional medical, surgical, trauma, military, and consumer OTC (over the counter) applications.

Tricol Biomedical, Inc. is a wholly owned independent subsidiary of Tricol International Group, Ltd., a Marshall Islands company, substantially owned by Weifang Tricol Trading Co. Ltd.  the largest manufacturer in Asia for microfiber products, with capabilities of manufacturing chitosan microfibers and non-woven sheets and films.

Tricol is a strong supplier of microfiber technologies brands worldwide for healthcare and cleaning products. Tricol acquired HemCon Medical Technologies, Inc. in April 2016.

Tricol Biomedical is headquartered in Portland, Oregon with a wholly owned operating subsidiary in Ireland (HemCon Medical Technologies Europe Ltd.) and the Czech Republic (HemCon Medical Technologies CZ s.r.o.).

Tricol Biomedical, Inc. is ISO 13485 certified.


720 SW Washington Street, Suite 200
Portland, Oregon 97205-3504
United States

Get Directions

Upgrade Your Listing